Efficacy and safety of a novel hyaluronic acid dermal filler containing lidocaine for treatment of nasolabial folds in Fitzpatrick skin types IV to VI

2010 ◽  
Vol 62 (3) ◽  
pp. AB141
Keyword(s):  
Hyaluronic Acid ◽  
Dermal Filler ◽  
Efficacy And Safety ◽  
Nasolabial Folds

scholarly journals An Open-Label Uncontrolled, Multicenter Study for the Evaluation of the Efficacy and Safety of the Dermal Filler Princess VOLUME in the Treatment of Nasolabial Folds

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Daisy Kopera ◽  
Michael Palatin ◽  
Rolf Bartsch ◽  
Katrin Bartsch ◽  
Maria O’Rourke ◽  
...  
Keyword(s):  
Hyaluronic Acid ◽  
Adverse Events ◽  
Multicenter Study ◽  
Dermal Filler ◽  
Nasolabial Fold ◽  
Efficacy And Safety ◽  
Open Label ◽  
Moderate Severity ◽  
Injection Site Reactions ◽  
Nasolabial Folds

The dermal filler Princess VOLUME is a highly cross-linked, viscoelastic hyaluronic acid injectable gel implant used for aesthetic treatment. To evaluate the efficacy and safety of Princess VOLUME in the treatment of nasolabial folds, an open-label uncontrolled, multicenter study was conducted. Forty-eight subjects were recruited who had moderate to deep wrinkles, according to the Modified Fitzpatrick Wrinkle Scale (MFWS). Subjects received Princess VOLUME in both nasolabial folds at Day 0. Nasolabial fold severity was evaluated at 30, 90, 180, and 270 days after treatment, using the MFWS and the Global Aesthetic Improvement Scale (GAIS). Adverse events and treatment site reactions were recorded. Among the 48 subjects, 93.8% were female with a median age of 52 years. There were significant improvements(P<0.0001)in the MFWS scores at 30, 180, and 270 days after treatment compared with those at baseline, with a mean decrease of 1.484 (±0.408), 1.309 (±0.373), and 1.223 (±0.401), respectively; hence the primary endpoint was achieved and clinical efficacy demonstrated. Princess VOLUME was well tolerated, and most adverse events were injection site reactions of mild to moderate severity. Subject satisfaction (97.9%), subject recommendation of the treatment (93.6%), and investigators GAIS scores (97.9% improvement) were high.

Efficacy and safety of a new monophasic hyaluronic acid filler in the correction of nasolabial folds: a randomized, evaluator-blinded, split-face study

2013 ◽  
Vol 25 (5) ◽  
pp. 448-452 ◽  
Author(s):  
Do Young Rhee ◽  
Chong Hyun Won ◽  
Sung Eun Chang ◽  
Tai Kyung Noh ◽  
Myoung Shin Kim ◽  
...  
Keyword(s):  
Hyaluronic Acid ◽  
Efficacy And Safety ◽  
Nasolabial Folds ◽  
Split Face

The efficacy and safety of a monophasic hyaluronic acid filler in the correction of nasolabial folds: A randomized, multicenter, single blinded, split-face study

2017 ◽  
Vol 17 (4) ◽  
pp. 584-589
Author(s):  
Hyun Jung Kwon ◽  
Eun Jung Ko ◽  
Sun Young Choi ◽  
Eun Ja Choi ◽  
Yu-Jin Jang ◽  
...  
Keyword(s):  
Hyaluronic Acid ◽  
Efficacy And Safety ◽  
Nasolabial Folds ◽  
Split Face
Sign in / Sign up

Export Citation Format

Share Document